700 patients110,866 observations180 daysLIVE

Patient P-02439

Synthetic patientMETA-24 · Day 171 · 45–54 · F · baseline S08Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
13%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S08
  2. Day 23 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 108 BR-03 recommendedBehavioural Recommendation BR-03
  4. Day 109 Patient acceptedStarted BR-03 in the companion
  5. Day 116 No meaningful changeBehavioural Recommendation BR-03

What changed?

Trajectory began diverging from predicted response on Day 23.

Primary contributors, last 14 days
  • GI instability-16
  • Inflammatory activity-16
  • Toxicity-14
  • Nutritional resilience+13
  • Treatment adherence-3

What helped?

  • Behavioural Recommendation BR-03Day 108
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
54 min
stable · -0.9 vs previous 14 d
Sleep duration
Wearable
5.5 h
stable · -0.2 vs previous 14 d
Energy level
Daily log
5.8/10
worsening · -0.4 vs previous 14 d
Steps
Wearable
6,187
stable · -118 vs previous 14 d
GI burden
Companion
20.9/100
worsening · +8.8 vs previous 14 d
Adherence
Companion
83.4 %
stable · -3.4 vs previous 14 d
Sleep quality
Wearable
36.5/100
worsening · -6.2 vs previous 14 d
Glucose, CGM daily mean
CGM
145 mg/dL
worsening · +5.4 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 71 from the failing basin, 38 from restoration.

Good elements to keep
  • Protein (supports)
    perturbation · steering +14.9
  • Behavioural Recommendation BR-03
    intervention · steering +8.6
  • Butyrate producers intact
    hidden · steering +7.5
  • Protein
    supporter · GI -7.8 next day
Main detractors to watch
  • Bacteroides fragilis elevated
    hidden · steering -7.4
  • IL6 high-expression variant
    hidden · steering -7.3
  • Antibiotic course
    perturbation · steering -4.7
  • Poor-sleep week
    perturbation · steering -3
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -7.8supporter · 95%
  • Histamine load
    -2.6no signal · 46%
  • Ultra-processed food
    +2.3no signal · 40%
  • Dietary fat load
    +1.7no signal · 25%
  • Alcohol
    -1.4no signal · 26%
  • Simple carbohydrates
    -1.3no signal · 20%
  • Caffeine
    +0.4no signal · 15%
  • Insoluble fibre
    +0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 45
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • MicrobiomeBacteroides fragilis expansion
  • Autonomic recovery 20
    • WearableShort sleep window
  • Mucosal barrier integrity 10
    • WearableSleep 5.5 h, below personal baseline
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 4.4 · butyrate capacity 54/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
52 ms
Sleep
5.6 h
Steps
5,817
Resting HR
69 bpm
Daily log: GI score 21, nutritional resilience 70, adherence 83.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Keep fibre steady; no new sources this week
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0269828%S06ME-01improved71
P-0221429%S08SC-12no change69
P-0208327%S1369
P-0229328%S15HY-01no change68
P-0209027%S0468
P-0246328%S1868
P-0263728%S1167
P-0265828%S0466
P-0210927%S0466
P-0209529%S0866
P-0249529%S0566
P-0247630%S0565